THE Australian Medical
Association and the Royal
Australian and NZ College of
Ophthalmologists says they strongly
disagree with this month’s
rescheduling of chloramphenical
eye drops from prescription-only to
S3, with RANZCO President Dr
Richard Stawell saying the
medicine should be reserved for
bacterial eye infections.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 07 May 10
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 May 10
